239 related articles for article (PubMed ID: 2169337)
1. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B
Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of Shionogi carcinoma 115 cells by glucocorticoid-induced autocrine heparin-binding growth factor(s) in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Nishizawa Y; Terada N; Matsumoto K; Sato B
Cancer Res; 1991 Jun; 51(11):3006-10. PubMed ID: 2032238
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.
Lu J; Nishizawa Y; Tanaka A; Nonomura N; Yamanishi H; Uchida N; Sato B; Matsumoto K
Cancer Res; 1989 Sep; 49(18):4963-7. PubMed ID: 2766270
[TBL] [Abstract][Full Text] [Related]
4. Effects of androgen, fibroblast growth factors or other various growth factors on growth of Shionogi carcinoma cells in a protein-free medium.
Tanaka A; Lu J; Yamanishi H; Nonomura N; Yasui T; Maeyama M; Nishizawa Y; Matsumoto K; Sato B
Anticancer Res; 1990; 10(6):1637-41. PubMed ID: 2285236
[TBL] [Abstract][Full Text] [Related]
5. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive Shionogi carcinoma 115.
Kasayama S; Sumitani S; Tanaka A; Yamanishi H; Nakamura N; Matsumoto K; Sato B
J Cell Physiol; 1991 Aug; 148(2):260-6. PubMed ID: 1715343
[TBL] [Abstract][Full Text] [Related]
7. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K
Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.
Hiraoka D; Nakamura N; Nishizawa Y; Uchida N; Noguchi S; Matsumoto K; Sato B
Cancer Res; 1987 Dec; 47(24 Pt 1):6560-4. PubMed ID: 3677094
[TBL] [Abstract][Full Text] [Related]
9. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
[TBL] [Abstract][Full Text] [Related]
10. Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline 2).
Furuya Y; Sato N; Akakura K; Ichikawa T; Suzuki N; Sato R; Shimazaki J
Cancer Res; 1990 Aug; 50(16):4979-83. PubMed ID: 2379162
[TBL] [Abstract][Full Text] [Related]
11. Growth-stimulatory effect of androgen-induced autocrine growth factor(s) secreted from Shionogi carcinoma 115 cells on androgen-unresponsive cancer cells in a paracrine mechanism.
Nonomura N; Nakamura N; Uchida N; Noguchi S; Sato B; Sonoda T; Matsumoto K
Cancer Res; 1988 Sep; 48(17):4904-8. PubMed ID: 3409225
[TBL] [Abstract][Full Text] [Related]
12. Growth-stimulatory effects of androgen, high concentration of glucocorticoid or fibroblast growth factors on a cloned cell line from Shionogi carcinoma 115 cells in a serum-free medium.
Nakamura N; Yamanishi H; Lu J; Uchida N; Nonomura N; Matsumoto K; Sato B
J Steroid Biochem; 1989 Jul; 33(1):13-8. PubMed ID: 2788234
[TBL] [Abstract][Full Text] [Related]
13. Effects of thyroid hormone on androgen- or basic fibroblast growth factor-induced proliferation of Shionogi carcinoma 115 mouse mammary carcinoma cells in serum-free culture.
Sumitani S; Kasayama S; Hirose T; Matsumoto K; Sato B
Cancer Res; 1991 Aug; 51(16):4323-7. PubMed ID: 1868455
[TBL] [Abstract][Full Text] [Related]
14. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture.
Omukai Y; Nakamura N; Hiraoka D; Nishizawa Y; Uchida N; Noguchi S; Sato B; Matsumoto K
Cancer Res; 1987 Aug; 47(16):4329-34. PubMed ID: 3607765
[TBL] [Abstract][Full Text] [Related]
15. Effects of various growth factors on growth of a cloned human esophageal squamous cancer cell line in a protein-free medium.
Oku K; Tanaka A; Yamanishi H; Nishizawa Y; Matsumoto K; Shiozaki H; Mori T
Anticancer Res; 1991; 11(4):1591-5. PubMed ID: 1746916
[TBL] [Abstract][Full Text] [Related]
16. [Stimulation and inhibition of the growth of sex-steroid-dependent tumors].
Matsumoto K; Nakamura N; Sato B
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):771-9. PubMed ID: 3566289
[TBL] [Abstract][Full Text] [Related]
17. Unsaturated fatty acids are required for continuous proliferation of transformed androgen-dependent cells by fibroblast growth factor family proteins.
Kasayama S; Koga M; Kouhara H; Sumitani S; Wada K; Kishimoto T; Sato B
Cancer Res; 1994 Dec; 54(24):6441-5. PubMed ID: 7987840
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
19. Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma.
Blanckaert VD; Schelling ME; Elstad CA; Meadows GG
Cancer Res; 1993 Sep; 53(17):4075-81. PubMed ID: 8358737
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
